Loading…
Employees: 1,771
Size ChemPartner PharmaTech (300149.SZ) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $645M, the 3251st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥8.55 on 6 Nov 2026.
Performance Over six months the shares fell 14.4%, against -16.5% for the median peer and -16.4% for the China market (cap-weighted) — 11th highest of 21 in its peer set.
Growth Revenue grew 18.4% over the last twelve months (peer median +3.9%); the operating margin is 2.2% (peer median 7.9%).
Valuation It trades at 3.5× enterprise value to sales against a peer median of 3.1× (10th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 26% a year for seven years (Req g). Recent delivered growth is -5%, so the hurdle is +31 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 2.9 points below its cost of capital (10.8% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.27B | CN¥1.13B | CN¥968M | CN¥1.14B | CN¥1.32B |
| Revenue growth | — | +17% | -15% | -14% | — |
| Gross profit | CN¥456M | CN¥301M | CN¥190M | CN¥273M | CN¥290M |
| EBITDA | n/a | CN¥170M | CN¥77.8M | CN¥125M | CN¥149M |
| Net income | -CN¥7.00M | CN¥13.4M | -CN¥226M | -CN¥917M | CN¥379M |
| Free cash flow | CN¥84.3M | CN¥128M | CN¥98.6M | -CN¥49.7M | -CN¥73.4M |
| Capital expenditure | CN¥87.2M | CN¥62.5M | CN¥69.2M | CN¥201M | CN¥336M |
| Total debt | CN¥490M | CN¥472M | CN¥513M | CN¥635M | CN¥966M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300149.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.5% | -7.8% | 9th lowest of 21 |
| 6-month return | -14.4% | -16.5% | 11th highest of 21 |
| Distance from 52-week high | -39.9% | -44.1% | 10th highest of 21 |
| Revenue growth (TTM) | +18.4% | +3.9% | 5th highest of 21 |
| Operating margin | 2.2% | 7.9% | 5th lowest of 21 |
| EV / Sales | 3.5× | 3.1× | 10th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 25.6% | 7.0% | 4th most demanding of 15 |
| Growth delivered (Del g) | -5.2% | +5.7% | lowest of 15 |
| Hurdle (Req g minus delivered) | +30.8 pp | -2.8 pp | 2nd most demanding of 15 |
| ROIC minus cost of capital | -2.9 pp | -2.6 pp | 10th lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| ChemPartner PharmaTech 300149.SZ | China | $645M | -14% | +18% | 2% | 3.5× | 25.6% | -5.2% |
| Intrum INTRUM.ST | Sweden | $645M | -53% | -4% | 28% | 2.6× | -8.9% | +0.2% |
| BELLSYSTEM24 6183.T | Japan | $637M | -10% | +1% | 8% | 1.0× | -5.7% | +1.4% |
| Framery FRAMERY.HE | Finland | $632M | 0% | +37% | 20% | 2.8× | 5.9% | +13.4% |
| Matrix Design 301365.SZ | China | $660M | -31% | +9% | 4% | 4.5× | 29.3% | +3.6% |
| IBEX IBEX | United States | $661M | +53% | +15% | 9% | 1.1× | 0.3% | +7.7% |
| Guangzhou Doppler Electronic Technologies 301528.SZ | China | $663M | -5% | +35% | 22% | 12.7× | 42.2% | +11.8% |
| Hangzhou MDK Opto Electronic 688079.SS | China | $666M | -28% | +30% | -26% | 8.4× | n/a | n/a |
| LEPU ScienTech Medical Technology (Shanghai) 2291.HK | Hong Kong | $624M | +25% | -4% | 42% | 6.0× | -8.4% | +28.0% |
| Medlive Technology 2192.HK | Hong Kong | $621M | -25% | +6% | 29% | 2.6× | -0.3% | +23.8% |
| Pourin Special Welding Technology 301468.SZ | China | $621M | -40% | -4% | 5% | 7.2× | n/a | n/a |
| Strike 6196.T | Japan | $618M | +29% | +33% | 38% | 2.6× | n/a | n/a |
| Yokorei 2874.T | Japan | $617M | 0% | +1% | 5% | 1.6× | n/a | n/a |
| China Design 603018.SS | China | $616M | -20% | -8% | 7% | 0.8× | -8.0% | -5.1% |
| RWS RWS.L | United Kingdom | $677M | +46% | -1% | 4% | 0.8× | 11.5% | +14.2% |
| NCS Testing Technology 300797.SZ | China | $678M | -26% | +15% | 7% | 3.4× | 22.3% | +15.0% |
| China Education 0839.HK | Hong Kong | $680M | -4% | +9% | 32% | 1.7× | n/a | n/a |
| FS Development Investment 300071.SZ | China | $612M | -13% | -41% | -18% | 6.7× | 34.6% | +1.0% |
| M-Grass Ecology And Environment (Group) 300355.SZ | China | $611M | -30% | -23% | -13% | 5.1× | 11.6% | +0.5% |
| Grand Sunergy Tech 603778.SS | China | $686M | -73% | -54% | -98% | 7.8× | n/a | n/a |
| Suzhou Electrical Apparatus Science Academy 300215.SZ | China | $605M | -36% | +8% | 9% | 6.4× | 8.1% | -4.9% |